CN105194117A - Traditional Chinese medicine composition for treating leukemia - Google Patents
Traditional Chinese medicine composition for treating leukemia Download PDFInfo
- Publication number
- CN105194117A CN105194117A CN201310107490.0A CN201310107490A CN105194117A CN 105194117 A CN105194117 A CN 105194117A CN 201310107490 A CN201310107490 A CN 201310107490A CN 105194117 A CN105194117 A CN 105194117A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- pancreas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating leukemia and belongs to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine composition is a leukemia treatment traditional Chinese medicine composition with a low price and eating convenience. The traditional Chinese medicine composition comprises, by weight, 10-20 parts of herba violae, 20-30 parts of limonite, 25-35 parts of mulberry and 42-55 parts of pancreas. The traditional Chinese medicine composition is used for treating leukemia and has effects of removing toxins and removing stasis, cooling blood and strengthening body resistance, and invigorating spleen, benefiting marrow and nourishing blood.
Description
Technical field
One of the present invention treats leukemic Chinese medicine composition, belongs to Chinese herbal medicine preparation technology field.
Background technology
Leukemia is the Clonal malignant disease of a class hematopoietic stem cell exception, leukemia expert has confirmed several situation of bringing out leukemia cause, as factors such as virus, radiation, chemical substance, heredity, current Therapeutic Method is mainly: Supporting Therapy, chemotherapy, bone marrow transplantation and targeted therapy etc., therapeutic process is painful, costly, ordinary people is difficult to bear.
From the Chinese point of view, the leukemic cause of disease is knot in the expectorant stasis of blood nothing more than three kinds: one: dysfunction of the spleen in transportation, wet consor expectorant, intemperance of taking food, overstrain.By feelings will, the not strongly fragrant and mental status not good mental disorder always knot is poly-, obstruction by phlegm, with the passing of time becomes expectorant poison, disease amasss all cards; Two is pyretic toxicity invasion and attack: pathogenic fire pyretic toxicity invasion and attack the exterior and the interior or diseases caused by exogenous pathogenic factor initiation are got angry, Fu Huo, so that drug-pedlar's nutrient blood, and poison damages bone marrow, and consumption hinders vigour, forms labor disease; Three is damage in visceral-qi: because void causes patient with the cloudy damage of essence void of internal organs QI and blood for ill principal element, spleen kidney two is dirty first to be damaged, and battalion Wei Zhiqi becomes estranged, and causes heresy poison to be taken advantage of a weak point in opponent's defence and invades, the cloudy Tianjin of wasting QI-blood, and evil poison is detained and is not gone, and formation consumptive disease is long-pending, the malicious node of expectorant.
Chinese medicine thinks that the leukemic cause of disease is mainly healthy energy virtual loss, caused by pyretic toxicity heresy.Exactly because healthy energy collapse just causes in evil poison invasion and attack body." General Treatise on the Cause and Symptoms of Diseases asthenia opinion " sayed: " the kidney generating marrow and dominating bone, asthenia damages blood consumption marrow." kidney is the healthy energy of human body the congenital foundation, main the whole body, the spleen being the foundation of acquired constitution is people's body source of generating QI and blood.Body congenital defect or lack of proper care after one's birth, all can cause the dirty loss of spleen kidney two, and then involve the loss of other organs, cause eventually just lose be unequal to evil, warm poison evil invasion body, hinders smart hematozemia, attacks note bone marrow, damage its normal hemopoietic function, qi-blood-body fluid is disorderly, causes leukemia eventually.I.e. so-called " healthy energy internal memory, heresy can not be done ", " gathering of heresy, its gas must be empty ".Find out thus, the leukemic cause of disease is closely related with spleen kidney.
Summary of the invention
The present invention overcomes the deficiencies in the prior art, and technical problem to be solved is, provides a kind of cheap, the leukemic Chinese medicine composition for the treatment of of taking convenience.
For solving the problems of the technologies described above, the technical solution used in the present invention is: one treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 10 ~ 20 parts, Limonitum 20 ~ 30 parts, Fructus Mori 25 ~ 35 parts, 42 ~ 55 parts, pancreas.
As preferably, one treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 13 ~ 17 parts, Limonitum 22 ~ 28 parts, Fructus Mori 27 ~ 33 parts, 45 ~ 52 parts, pancreas.
Herba Violae: bitter in the mouth, cold in nature, GUIXIN, Liver Channel, clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling;
Limonitum: sweet in the mouth, puckery, property is put down, and enters spleen, stomach, large intestine channel, and astringing intestine to stop diarrhea stops blooding, main chronic diarrhea, chronic dysentery;
Fructus Mori: sweet in the mouth, acid, cold in nature, return liver, kidney channel, nourishing YIN and supplementing blood, promote the production of body fluid and moisturize;
Pancreas: sweet in the mouth, property is put down, and micro-poison, returns lung, spleen, large intestine channel, lung benefiting, spleen reinforcing, moisturize.
Described pancreas is Pancreas Sus domestica or Pancreas caprae seu ovis.
The present invention in use, the above-mentioned raw materials weight of one person-portion in gram, described Herba Violae and Limonitum are decocted soup, get the pancreas that its clear soup adds Fructus Mori and healthy animal, pancreas segmentation taken after boiling, weakling divides three decoction being taken at a draught use, and the good person of body constitution divides two decoction being taken at a draught to use, within ten days, taking once, three months is a course for the treatment of.
The beneficial effect that the present invention compared with prior art has is: the present invention can detoxicating blood stasis dispelling, removing heat from blood righting, spleen reinforcing benefit marrow hemopoietic, eliminating pathogenic factor for supporting vital QI, QI invigorating nutrient blood, while curing the disease, is progressively in harmonious proportion health negative and positive, strong patient's body constitution.
Case one
Patient's first, female, 21 years old, check result was hematochrome 4.5g, leukocyte 2000/mm
3, platelet 2.3 ten thousand/mm
3, take Chinese medicine of the present invention half a year, review result is hematochrome hematochrome 12g, leukocyte 6600/mm
3, platelet 170,000/mm
3.
Case two
Patient's second, man, 27 years old, check result was hematochrome 10.28g, leukocyte 2500/mm
3, platelet 11.8 ten thousand/mm
3, take Chinese medicine of the present invention 5 months, review result is hematochrome hematochrome 12.88g, leukocyte 7300/mm
3, platelet 230,000/mm
3.
Case three
Patient the third, man, 35 years old, and check result is that germinal cell adds juvenile cell and reaches 80.5%, hematochrome 5.56g, leukocyte 700/mm
3, erythrocyte 760,000/mm
3, platelet 0.8 ten thousand/mm
3, take Chinese medicine of the present invention 8 months, review result is that germinal cell adds juvenile cell and drops to 3.5%, hematochrome 12g, leukocyte 8800/mm
3, erythrocyte 4,470,000/mm
3, platelet 230,000/mm
3.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment one
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 10 parts, Limonitum 20 parts, Fructus Mori 25 parts, 45 parts, pancreas.
Embodiment two
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 14 parts, Limonitum 28 parts, Fructus Mori 33 parts, 55 parts, pancreas.
Embodiment three
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 13 parts, Limonitum 22 parts, Fructus Mori 29 parts, 52 parts, pancreas.
Embodiment four
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 16 parts, Limonitum 23 parts, Fructus Mori 27 parts, 48 parts, pancreas.
Embodiment five
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 20 parts, Limonitum 30 parts, Fructus Mori 35 parts, 45 parts, pancreas.
Embodiment six
One treats leukemic Chinese medicine composition, comprises the raw material of following weight: Herba Violae 17 parts, Limonitum 26 parts, Fructus Mori 31 parts, 42 parts, pancreas.
The present invention can summarize with other the concrete form without prejudice to spirit of the present invention or principal character.Therefore, no matter from that, above-mentioned embodiment of the present invention all can only be thought explanation of the present invention and can not limit invention, claims indicate scope of the present invention, and scope of the present invention is not pointed out in above-mentioned explanation, therefore, any change in the implication suitable with claims of the present invention and scope, all should think to be included in the scope of claims.
Claims (2)
1. treat a leukemic Chinese medicine composition, it is characterized in that the raw material comprising following weight: Herba Violae 10 ~ 20 parts, Limonitum 20 ~ 30 parts, Fructus Mori 25 ~ 35 parts, 42 ~ 55 parts, pancreas.
2. one according to claim 1 treats leukemic Chinese medicine composition, it is characterized in that the raw material comprising following weight: Herba Violae 13 ~ 17 parts, Limonitum 22 ~ 28 parts, Fructus Mori 27 ~ 33 parts, 45 ~ 52 parts, pancreas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310107490.0A CN105194117A (en) | 2013-03-30 | 2013-03-30 | Traditional Chinese medicine composition for treating leukemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310107490.0A CN105194117A (en) | 2013-03-30 | 2013-03-30 | Traditional Chinese medicine composition for treating leukemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105194117A true CN105194117A (en) | 2015-12-30 |
Family
ID=54942302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310107490.0A Pending CN105194117A (en) | 2013-03-30 | 2013-03-30 | Traditional Chinese medicine composition for treating leukemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105194117A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174065A (en) * | 1997-07-16 | 1998-02-25 | 迟经惠 | Injection for dysfunctional anemia |
| CN1408404A (en) * | 2002-07-22 | 2003-04-09 | 周宝义 | Cancer curing medicine |
| CN1864737A (en) * | 2005-05-17 | 2006-11-22 | 刘进曙 | Powder dedicated for treating leukemia and preparation method thereof |
| CN102018877A (en) * | 2009-09-11 | 2011-04-20 | 郁华军 | Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
-
2013
- 2013-03-30 CN CN201310107490.0A patent/CN105194117A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174065A (en) * | 1997-07-16 | 1998-02-25 | 迟经惠 | Injection for dysfunctional anemia |
| CN1408404A (en) * | 2002-07-22 | 2003-04-09 | 周宝义 | Cancer curing medicine |
| CN1864737A (en) * | 2005-05-17 | 2006-11-22 | 刘进曙 | Powder dedicated for treating leukemia and preparation method thereof |
| CN102018877A (en) * | 2009-09-11 | 2011-04-20 | 郁华军 | Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103194360B (en) | Medicinal liquor with healthcare function as well as preparation method and application thereof | |
| CN105920362A (en) | Dendrobium officinale liquor and preparation method thereof | |
| CN104415290A (en) | Stagnation-removing decoction oral liquid and preparation method thereof | |
| CN103041341B (en) | Traditional Chinese medicine composition for curing tuberculous exadative pleurisy and preparation method thereof | |
| CN103931846A (en) | Health care tea capable of reducing uric acid | |
| CN104645010A (en) | Acute and chronic pharyngitis tea and preparation process thereof | |
| CN103735937B (en) | There is the medicine and health products promoting ferrous components to absorb and to enrich blood | |
| CN102920775A (en) | Traditional Chinese medicine for preventing and treating hyperlipidemia | |
| CN104287015A (en) | Exocarpium citri rubrum health drink and preparation method thereof | |
| CN103893620B (en) | Chinese medicinal composition for preventing and treating diabetes and preparation method thereof | |
| CN105194117A (en) | Traditional Chinese medicine composition for treating leukemia | |
| CN103816399B (en) | A kind of Chinese medicine preparation being used for the treatment of hundstaupe pyreticosis | |
| CN107805577A (en) | A kind of preparation method of Jewel orchid healthcare wine | |
| CN102174361B (en) | Cistanche deseuticola health-care wine and preparation method thereof | |
| CN106728835B (en) | A kind of Chinese medicine for treating diabetes | |
| CN103690902B (en) | For preventing the Chinese medicine preparation of nasopharyngeal carcinoma radiation side reaction | |
| CN102139015B (en) | Medicinal liquor capable of balancing yin and yang and improving immunity and preparation thereof | |
| CN104784474B (en) | A kind of life-prolonging medicated wine and preparation method thereof | |
| CN101161808B (en) | Medicine wine containing total scorpion or scorpion toxin, or dioscorea nipponica | |
| CN104095124A (en) | Herbal tea and preparation method thereof | |
| CN104187922B (en) | A kind of have improve plant society and the application thereof of state after drinking | |
| CN103638255B (en) | A kind of Traditional Chinese drug mixture for the treatment of consumptive disease and preparation method thereof | |
| CN103461591A (en) | Food type liver-nourishing tea granule capable of preventing and controlling alcoholic liver | |
| CN1063065C (en) | Decoction forgastritis | |
| CN107574095A (en) | A kind of double snake wine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151230 |
|
| RJ01 | Rejection of invention patent application after publication |